CYP7B1 and Insulin resistance: Interestingly, Kakiyama et al. reported data showing that an inability to upregulate CYP7B1, in the setting of insulin resistance, results in the accumulation of toxic intracellular cholesterol metabolites that promote inflammation and hepatocyte injury [21].